Cite
Development and Assessment of 1,5-Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK-2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation.
MLA
Abdelrahman, Kamal S., et al. “Development and Assessment of 1,5-Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK-2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation.” Molecules (Basel, Switzerland), vol. 28, no. 18, Sept. 2023. EBSCOhost, https://doi.org/10.3390/molecules28186521.
APA
Abdelrahman, K. S., Hassan, H. A., Abdel-Aziz, S. A., Marzouk, A. A., Shams, R., Osawa, K., Abdel-Aziz, M., & Konno, H. (2023). Development and Assessment of 1,5-Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK-2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation. Molecules (Basel, Switzerland), 28(18). https://doi.org/10.3390/molecules28186521
Chicago
Abdelrahman, Kamal S, Heba A Hassan, Salah A Abdel-Aziz, Adel A Marzouk, Raef Shams, Keima Osawa, Mohamed Abdel-Aziz, and Hiroyuki Konno. 2023. “Development and Assessment of 1,5-Diarylpyrazole/Oxime Hybrids Targeting EGFR and JNK-2 as Antiproliferative Agents: A Comprehensive Study through Synthesis, Molecular Docking, and Evaluation.” Molecules (Basel, Switzerland) 28 (18). doi:10.3390/molecules28186521.